My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Farmacia Hospitalaria
On-line version ISSN 2171-8695Print version ISSN 1130-6343
Abstract
FERNANDEZ-FERREIRO, Anxo et al. Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis. Farm Hosp. [online]. 2017, vol.41, n.6, pp.678-687. ISSN 2171-8695. https://dx.doi.org/10.7399/fh.10834.
Ocular cystinosis is a rare disease characterised by the deposition on the corneal surface of cystine crystals that hinder the eyesight of patients. Oral cysteamine is administered as cysteamine bitartrate; however, due to the lack of corneal vascularization it does not reach the cornea and must be administered by the topical ocular route. The aim of the present study was to determine the stability of an ophthalmic hydrogel of cysteamine under different preservation conditions during a follow-up of 30 days. This hydrogel could be prepared in hospital pharmacy services.
Several physical and chemical parameters were assessed: osmolality, pH, and cysteamine concentration, which was measured using an ultra-performance liquid chromatography-tandem mass spectrometer (UPLC-MS/ MS) method. Descriptive tests were also performed, such as transparency measurements and microbiological assays in order to verify sterility.
The results show that cysteamine hydrogel is stable over 30 days and should be preserved under refrigeration.
Keywords : Cysteamine; Ellman’s reagent; Hyaluronic acid; Mass spectrometry; Ocular cystinosis; Ophthalmic hydrogel; Stability.